| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,705 |
10,788 |
$393K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,868 |
1,786 |
$165K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,846 |
1,822 |
$164K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,203 |
1,166 |
$101K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,209 |
1,157 |
$61K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
570 |
568 |
$49K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,976 |
3,484 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,186 |
1,145 |
$21K |
| 99381 |
|
92 |
89 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
379 |
371 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
79 |
77 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
56 |
53 |
$2K |
| 92567 |
|
596 |
576 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
199 |
196 |
$1K |
| 90707 |
|
237 |
227 |
$300.27 |
| 87807 |
|
50 |
44 |
$209.66 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
32 |
26 |
$190.62 |
| 90670 |
|
1,223 |
1,191 |
$121.47 |
| 36415 |
Collection of venous blood by venipuncture |
27 |
27 |
$75.00 |
| 81002 |
|
61 |
61 |
$66.92 |
| 94667 |
|
25 |
25 |
$59.32 |
| 90633 |
|
420 |
418 |
$52.03 |
| 90658 |
|
48 |
47 |
$36.33 |
| 90651 |
|
116 |
116 |
$30.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
39 |
39 |
$21.40 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
29 |
24 |
$12.60 |
| 90686 |
|
92 |
92 |
$10.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
25 |
25 |
$0.03 |
| 92551 |
|
163 |
153 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
967 |
959 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
343 |
338 |
$0.00 |
| 99174 |
|
1,915 |
1,872 |
$0.00 |
| 90698 |
|
1,238 |
1,211 |
$0.00 |
| 90716 |
|
281 |
271 |
$0.00 |
| 90744 |
|
288 |
279 |
$0.00 |
| 90619 |
|
37 |
37 |
$0.00 |
| 90680 |
|
12 |
12 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
286 |
280 |
$0.00 |
| 90715 |
|
15 |
15 |
$0.00 |
| 90681 |
|
186 |
179 |
$0.00 |
| 99173 |
|
111 |
101 |
$0.00 |
| 90734 |
|
25 |
25 |
$0.00 |
| 90461 |
|
22 |
22 |
$0.00 |